PENZBERG, Germany--(BUSINESS WIRE)--Roche Diagnostics and Exiqon A/S, Vedbæk, Denmark, a provider of high-value gene expression analysis products, announced that they have entered into a license agreement for use of SYBR Green reagent in PCR. Under the terms of the agreement, Exiqon obtains from Roche a non-exclusive license to use SYBR Green I in Real Time PCR. SYBR Green provides the simplest and most economical format for detecting and quantitating PCR products in Real-Time PCR reactions. Financial terms of the agreement were not disclosed.